Acute Leukemias VI: Prognostic Factors and Treatment Strategies
For 10 years the book series Acute Leukemias has been providing updates on the rapid progress being made internationally concerning this group of diseases. The fifth volume mainly addressed experimental approaches, but the present issue presents both therapeutic and prognostic aspects of the most re...
Gespeichert in:
| Weitere Verfasser: | , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1997
|
| Schriftenreihe: | Haematology and Blood Transfusion Hämatologie und Bluttransfusion
38 |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | For 10 years the book series Acute Leukemias has been providing updates on the rapid progress being made internationally concerning this group of diseases. The fifth volume mainly addressed experimental approaches, but the present issue presents both therapeutic and prognostic aspects of the most recent results from major multicenter clinical trials. Additional chapters report new trends in leukemia cell biology,the monitoring of minimal residual disease, and secondary leukemias, as well as new antileukemic drugs, antimicrobial strategies, and the use of cytokines. The combined efforts against acute leukemias described in this book explain the recent improvements in the outcome of patients suffering from acute leukemias |
| Beschreibung: | 1 Online-Ressource (XXXIV, 997 p) |
| ISBN: | 9783642603778 |
| DOI: | 10.1007/978-3-642-60377-8 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046147150 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1997 |||| o||u| ||||||eng d | ||
| 020 | |a 9783642603778 |9 978-3-642-60377-8 | ||
| 024 | 7 | |a 10.1007/978-3-642-60377-8 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-642-60377-8 | ||
| 035 | |a (OCoLC)1119082435 | ||
| 035 | |a (DE-599)BVBBV046147150 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.15 |2 23 | |
| 245 | 1 | 0 | |a Acute Leukemias VI |b Prognostic Factors and Treatment Strategies |c edited by T. Büchner, G. Schellong, J. Ritter, U. Creutzig, W. Hiddemann, B. Wörmann |
| 264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1997 | |
| 300 | |a 1 Online-Ressource (XXXIV, 997 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Haematology and Blood Transfusion Hämatologie und Bluttransfusion |v 38 | |
| 520 | |a For 10 years the book series Acute Leukemias has been providing updates on the rapid progress being made internationally concerning this group of diseases. The fifth volume mainly addressed experimental approaches, but the present issue presents both therapeutic and prognostic aspects of the most recent results from major multicenter clinical trials. Additional chapters report new trends in leukemia cell biology,the monitoring of minimal residual disease, and secondary leukemias, as well as new antileukemic drugs, antimicrobial strategies, and the use of cytokines. The combined efforts against acute leukemias described in this book explain the recent improvements in the outcome of patients suffering from acute leukemias | ||
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Toxicology | |
| 700 | 1 | |a Büchner, T. |4 edt | |
| 700 | 1 | |a Schellong, G. |4 edt | |
| 700 | 1 | |a Ritter, J. |4 edt | |
| 700 | 1 | |a Creutzig, U. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642643798 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540607632 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642603785 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-60377-8 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031527335 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-642-60377-8 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180486099042304 |
|---|---|
| any_adam_object | |
| author2 | Büchner, T. Schellong, G. Ritter, J. Creutzig, U. |
| author2_role | edt edt edt edt |
| author2_variant | t b tb g s gs j r jr u c uc |
| author_facet | Büchner, T. Schellong, G. Ritter, J. Creutzig, U. |
| building | Verbundindex |
| bvnumber | BV046147150 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-642-60377-8 (OCoLC)1119082435 (DE-599)BVBBV046147150 |
| dewey-full | 616.15 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.15 |
| dewey-search | 616.15 |
| dewey-sort | 3616.15 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-642-60377-8 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02549nmm a2200505zcb4500</leader><controlfield tag="001">BV046147150</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1997 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642603778</subfield><subfield code="9">978-3-642-60377-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-60377-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-60377-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119082435</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046147150</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.15</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Acute Leukemias VI</subfield><subfield code="b">Prognostic Factors and Treatment Strategies</subfield><subfield code="c">edited by T. Büchner, G. Schellong, J. Ritter, U. Creutzig, W. Hiddemann, B. Wörmann</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XXXIV, 997 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Haematology and Blood Transfusion Hämatologie und Bluttransfusion</subfield><subfield code="v">38</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">For 10 years the book series Acute Leukemias has been providing updates on the rapid progress being made internationally concerning this group of diseases. The fifth volume mainly addressed experimental approaches, but the present issue presents both therapeutic and prognostic aspects of the most recent results from major multicenter clinical trials. Additional chapters report new trends in leukemia cell biology,the monitoring of minimal residual disease, and secondary leukemias, as well as new antileukemic drugs, antimicrobial strategies, and the use of cytokines. The combined efforts against acute leukemias described in this book explain the recent improvements in the outcome of patients suffering from acute leukemias</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Büchner, T.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schellong, G.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ritter, J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Creutzig, U.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642643798</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540607632</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642603785</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-60377-8</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031527335</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-60377-8</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046147150 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:31Z |
| institution | BVB |
| isbn | 9783642603778 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031527335 |
| oclc_num | 1119082435 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XXXIV, 997 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Springer Berlin Heidelberg |
| record_format | marc |
| series2 | Haematology and Blood Transfusion Hämatologie und Bluttransfusion |
| spelling | Acute Leukemias VI Prognostic Factors and Treatment Strategies edited by T. Büchner, G. Schellong, J. Ritter, U. Creutzig, W. Hiddemann, B. Wörmann Berlin, Heidelberg Springer Berlin Heidelberg 1997 1 Online-Ressource (XXXIV, 997 p) txt rdacontent c rdamedia cr rdacarrier Haematology and Blood Transfusion Hämatologie und Bluttransfusion 38 For 10 years the book series Acute Leukemias has been providing updates on the rapid progress being made internationally concerning this group of diseases. The fifth volume mainly addressed experimental approaches, but the present issue presents both therapeutic and prognostic aspects of the most recent results from major multicenter clinical trials. Additional chapters report new trends in leukemia cell biology,the monitoring of minimal residual disease, and secondary leukemias, as well as new antileukemic drugs, antimicrobial strategies, and the use of cytokines. The combined efforts against acute leukemias described in this book explain the recent improvements in the outcome of patients suffering from acute leukemias Hematology Oncology Pharmacology/Toxicology Oncology Toxicology Büchner, T. edt Schellong, G. edt Ritter, J. edt Creutzig, U. edt Erscheint auch als Druck-Ausgabe 9783642643798 Erscheint auch als Druck-Ausgabe 9783540607632 Erscheint auch als Druck-Ausgabe 9783642603785 https://doi.org/10.1007/978-3-642-60377-8 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Acute Leukemias VI Prognostic Factors and Treatment Strategies Hematology Oncology Pharmacology/Toxicology Oncology Toxicology |
| title | Acute Leukemias VI Prognostic Factors and Treatment Strategies |
| title_auth | Acute Leukemias VI Prognostic Factors and Treatment Strategies |
| title_exact_search | Acute Leukemias VI Prognostic Factors and Treatment Strategies |
| title_full | Acute Leukemias VI Prognostic Factors and Treatment Strategies edited by T. Büchner, G. Schellong, J. Ritter, U. Creutzig, W. Hiddemann, B. Wörmann |
| title_fullStr | Acute Leukemias VI Prognostic Factors and Treatment Strategies edited by T. Büchner, G. Schellong, J. Ritter, U. Creutzig, W. Hiddemann, B. Wörmann |
| title_full_unstemmed | Acute Leukemias VI Prognostic Factors and Treatment Strategies edited by T. Büchner, G. Schellong, J. Ritter, U. Creutzig, W. Hiddemann, B. Wörmann |
| title_short | Acute Leukemias VI |
| title_sort | acute leukemias vi prognostic factors and treatment strategies |
| title_sub | Prognostic Factors and Treatment Strategies |
| topic | Hematology Oncology Pharmacology/Toxicology Oncology Toxicology |
| topic_facet | Hematology Oncology Pharmacology/Toxicology Oncology Toxicology |
| url | https://doi.org/10.1007/978-3-642-60377-8 |
| work_keys_str_mv | AT buchnert acuteleukemiasviprognosticfactorsandtreatmentstrategies AT schellongg acuteleukemiasviprognosticfactorsandtreatmentstrategies AT ritterj acuteleukemiasviprognosticfactorsandtreatmentstrategies AT creutzigu acuteleukemiasviprognosticfactorsandtreatmentstrategies |